IMM0306 in Combination With Lenalidomide vs Placebo in Combination With Lenalidomide in Patients With Relapsed/Refractory Follicular Lymphoma

Clinical trial NCT07355283 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07355283
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed/Refractory Follicular Lymphoma

Start date: 2026-02-01
Primary completion: 2028-07-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.